SEARCH

SEARCH BY CITATION

References

  • 1
    McKee CM. Deaths in winter: can Britain learn from Europe? Eur J Epidemiol 1989; 5: 17882.
  • 2
    Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. The Eurowinter Group. Lancet 1997; 349: 13416.
  • 3
    Healy JD. Excess winter mortality in Europe: a cross country analysis identifying key risk factors. J Epidemiol Community Health 2003; 57: 7849.
  • 4
    Keatinge WR, Donaldson GC, Bucher K, Jendritzky G, Cordioli E, Martinelli M, Katsouyanni K, Kunst AE, McDonald C, Nayha S, Vuori I. Winter mortality in relation to climate. Int J Circumpolar Health 2000; 59: 1549.
  • 5
    Office for National Statistics. Statistical Bulletin: excess winter mortality in England and Wales, 2009/10 (provisional) and 2008/09 (final). 2010.
  • 6
    Curwen M. Seasonal Variations in Mortality: The Effect of Influenza and Temperature. London: HMSO, 1981.
  • 7
    Brock A. Excess winter mortality in England and Wales 2007/08 (provisional) and 2006/07 (final). Health Stat Q 2008; 40: 6676.
  • 8
    Woodhouse PR, Khaw KT, Plummer M, Foley A, Meade TW. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet 1994; 343: 4359.
  • 9
    Lowe GD. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 2006; 133: 23250.
  • 10
    Mavri A, Guzic-Salobir B, Salobir-Pajnic B, Keber I, Stare J, Stegnar M. Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease. Blood Coagul Fibrinolysis 2001; 12: 35965.
  • 11
    Rudnicka AR, Rumley A, Lowe GD, Strachan DP. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 2007; 115: 9961003.
  • 12
    Stout RW, Crawford VL, McDermott MJ, Rocks MJ, Morris TC. Seasonal changes in haemostatic factors in young and elderly subjects. Age Ageing 1996; 25: 2568.
  • 13
    Frohlich M, Sund M, Russ S, Hoffmeister A, Fischer HG, Hombach V, Koenig W. Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects. Arterioscler Thromb Vasc Biol 1997; 17: 26927.
  • 14
    Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation 2001; 103: 23237.
  • 15
    Lowe GD, Danesh J, Lewington S, Walker M, Lennon L, Thomson A, Rumley A, Whincup PH. Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J 2004; 25: 2529.
  • 16
    Thompson A, Lowe GD, Rumley A, Eiriksdottir G, Danesh J, Gudnason V. Tissue plasminogen activator, fibrin D-dimer and von Willebrand factor antigens and risk of future coronary heart disease. J Thromb Haemost 2010; 8: 23.
  • 17
    Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 2002; 23: 176470.
  • 18
    Walker M, Whincup PH, Shaper AG. The British Regional Heart Study 1975–2004. Int J Epidemiol 2004; 33: 118592.
  • 19
    Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002; 105: 178590.
  • 20
    Elford J, Phillips AN, Thomson AG, Shaper AG. Migration and geographic variations in ischaemic heart disease in Great Britain. Lancet 1989; 1: 3436.
  • 21
    Wannamethee SG, Whincup PH, Shaper AG, Rumley A, Lennon L, Lowe GD. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Thromb Haemost 2009; 7: 160511.
  • 22
    Nelson W, Tong YL, Lee JK, Halberg F. Methods for cosinor-rhythmometry. Chronobiologia 1979; 6: 30523.
  • 23
    Morris RW, Whincup PH, Lampe FC, Walker M, Wannamethee SG, Shaper AG. Geographic variation in incidence of coronary heart disease in Britain: the contribution of established risk factors. Heart 2001; 86: 27783.
  • 24
    Crawford VL, Sweeney O, Coyle PV, Halliday IM, Stout RW. The relationship between elevated fibrinogen and markers of infection: a comparison of seasonal cycles. QJM 2000; 93: 74550.
  • 25
    Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 629.
  • 26
    Smith NL, Huffman JE, Strachan DP, Huang J, Dehghan A, Trompet S, Lopez LM, Shin SY, Baumert J, Vitart V, Bis JC, Wild SH, Rumley A, Yang Q, Uitterlinden AG, Stott DJ, Davies G, Carter AM, Thorand B, Polasek O et al. Genetic predictors of fibrin d-dimer levels in healthy adults. Circulation 2011; 123: 186472.
  • 27
    Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 2003; 146: 94857.
  • 28
    Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66 155 cases and 91 307 controls. Lancet 2006; 367: 6518.
  • 29
    Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 184960.